ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In order to analyze the impact of BCR-ABL and JAK2V617F on ISG mRNA expression in primary cells, peripheral blood samples from healthy donors, BCR-ABL-positive CML patients, and JAK2V617F-positive PV patients were tested.